United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
United Therapeutics will host a public webcast Wednesday, July 30, 2025, at 9:00 a.m. Eastern Time. The webcast will be accessible via United Therapeutics' website at https://ir.unither.com/events-and-presentations. A rebroadcast of the webcast will be available for one year and can be accessed at the same location.
United Therapeutics: Enabling Inspiration
At United Therapeutics, our vision and mission are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.
You can learn more about what it means to be a PBC here: unither.com/PBC.
Forward-Looking Statements
Statements included in this press release that are not historical in nature are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, our efforts to innovate for the unmet medical needs of our patients, to benefit our other stakeholders, and to pursue our public benefit purpose of developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language, and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of July 16, 2025, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Retail traders are resurrecting a pandemic-era penny stock this week. Here's what's going on with Opendoor.
The pandemic darling Opendoor has plunged in price since its IPO. However, the stock price has surged over 100% in price in recent trading sessions. Retail traders are piling in after a hedge fund manager announced a bullish position. A hedge fund manager's X post, eager retail investors, and some good old-fashioned r/WallStreetBets due diligence have created the perfect recipe for a new meme stock this week. Opendoor stock has soared 90% in the last five days, with shares of the company now trading at $1.73. The move is an unexpected reversal for the online home flipper, which went public via a Chamath Palihapitiya SPAC back in 2020 and has largely been discarded by Wall Street as a languishing penny stock. Once valued at a market cap of over $15 billion and a peak stock price of $35, shares fell from grace post-pandemic as the housing market cooled and the company experienced inventory write-downs. It's yet to post an annual profit since going public. Just two months ago, the company received a warning from Nasdaq that it could be delisted after the stock price failed to break above $1 for 30 consecutive days. In June, Opendoor announced a special meeting for later this month to discuss a reverse stock split in the order of 1‑for‑10 or as much as 1‑for‑50 in order to boost the value of its outstanding shares. This embedded content is not available in your region. What's driving the latest rally? A main driver behind Opendoor's recent rally was a recent X post from EMJ Capital founder Eric Jackson, in which he detailed his firm's position and investment thesis for the stock, as well as an $82 price target. The Canadian hedge fund manager is confident that Opendoor is a deep value turnaround company, with the potential to grow revenues from roughly $5 billion in 2024 to $12 billion by 2029. Jackson cited Opendoor's cost cutting efforts and market leadership, as well as potential rate cuts as positive catalysts for the stock. He also called for management reforms within the company and better operational execution. In Jackson's view, the stock has the potential to become a "100-bagger," returning over 1,000%. It's not Jackson's first time betting on an unloved stock. He's known for his bullish stance on Carvana back in 2023, when shares of the company were trading at $11. His bullish call paid off, as Carvana is now trading at over $350 a share. Retail investors answered the call after Jackson posted his Opendoor thesis and revealed his position. The stock's trading volume is currently nearing 250 million, well above its 90-day average of roughly 85 million, according to Yahoo! Finance data. As of Thursday morning, Opendoor was the third most trending stock on the site. And even before Jackson's announcement, investors on r/WallStreetBets had been chatting about the stock, with one user posting two months ago that they had opened a $155,000 position in OpenDoor. On the investing forum StockTwits, Opendoor is rated "extremely bullish" on the site's sentiment tracker, with message volume surging over the past 24 hours. Opendoor also has another hallmark of a classic meme stock: high levels of short interest, with 135.8 million shares, or 22% of its float, loaned to short-sellers. It's a signal that institutional investors are betting against Opendoor and creates a potential set-up for a short squeeze, where rising prices force short sellers to buy back shares and cause the stock to rally even more. While retail investors might be betting on a comeback, Wall Street sees a tough path ahead for the stock in the sluggish US housing market. Goldman Sachs gives Opendoor a $0.90 price target and a sell rating. Read the original article on Business Insider Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
25 minutes ago
- Business Wire
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Capricor Therapeutics, Inc. ('Capricor' or 'the Company') (NASDAQ: CAPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 9, 2024, and July 10, 2025, inclusive (the 'Class Period'), are encouraged to contact the firm before September 15, 2025. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Capricor touted its successful movement towards FDA approval for its deramiocel drug candidate, such as a mid-cycle review with no important deficiencies and the planning of an advisory committee meeting. Despite this positivity, the Company was concealing adverse data from the Phase 2 HOPE-2 trial. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Capricor, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Yahoo
33 minutes ago
- Yahoo
Markets Reach New Closing Highs, Netflix Beats on Q2 Earnings
Thursday, July 17, 2025Another blissfully bullish day on the stock market saw the Dow grow +229 points, +0.52%, the S&P 500 +33, +0.54%, the Nasdaq +153 points, +0.74%, and the small-cap Russell 2000 led the way once again for the session: +27 points, +1.22%. The Dow is +4.56% year to date and +7.98% over the past year, the S&P +7.07% and +12.69% — the ninth all-time high this year so far — the Nasdaq +8.15% and +16.04%, and the Russell 2000 +1.07% and +0.64%.Bond yields moderated a bit, after moving higher on a bevy of strong economic reports this morning and the specter that a changing of the guard at the Fed will result in lower interest rates. Though Fed Chair Jerome Powell has until May 2026 to serve out his term, there has been open speculation this week that he could be replaced (much) sooner than that. The 10-year sits at +4.46%, the 2-year is +3.91% and the 30-year remains above +5.01%.Business Inventories for May came in earlier today at 0.0% for the second month in a row, as expected. This is the fourth month of the past 12 that has been flat; only one month, December had a negative print (-0.2%). Homebuilder Confidence for July reached 33, as expected, and slightly above the 32 reported the prior month. Q2 Earnings After the Bell: Netflix, Interactive Brokers Both BeatThe first of the so-called 'Magnificent 7' stocks has reported earnings this afternoon, with streaming giant Netflix NFLX outpacing estimates on its bottom line — earnings of $7.19 per share versus the $7.07 consensus — while basically in-line on the top: $11.08 billion versus $11.09 billion expected. Net income grew $3.1 billion, while Operating Margins came in at +34.1%.Revenue guidance for the full-year was raised to a range of $44.8-45.2 billion. It also marks Netflix's sixth-straight quarterly earnings beat, even though the company no longer posts subscriber numbers. Shares are down less than -1% in late trading, but the stock is already up +43% year to Rank #1 (Strong Buy)-rated Interactive Brokers IBKR outperformed on both top and bottom lines in its Q2 report out after today's closing bell. Earnings of 51 cents per share beat estimates by a solid nickel, while revenues reached $1.48 billion in the quarter, well ahead of the $1.36 billion analysts had been expecting. This is IBKR's third earnings beat in its last five quarters. Shares are up almost +5% in after-hours trading. What to Expect from the Stock Market FridayAhead of Friday's open, Housing Starts and Building Permits for June will be hitting the tape, expected up slightly on new starts and steady on permits. Also a preliminary read on Consumer Confidence comes out for July, expected to ramp up to 61.8 from 60.7 reported last month. Also, Q2 earnings season keeps the parade moving along, with results from 3M MMM, oilfield services company Schlumberger SLB, American Express AXP and more. Next week, the surge of earnings reports grows, and will include Alphabet GOOGL, Intel INTC and Tesla TSLA, among hundreds of or comments about this article and/or author? Click here>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intel Corporation (INTC) : Free Stock Analysis Report Schlumberger Limited (SLB) : Free Stock Analysis Report Netflix, Inc. (NFLX) : Free Stock Analysis Report 3M Company (MMM) : Free Stock Analysis Report American Express Company (AXP) : Free Stock Analysis Report Interactive Brokers Group, Inc. (IBKR) : Free Stock Analysis Report Tesla, Inc. (TSLA) : Free Stock Analysis Report Alphabet Inc. (GOOGL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
